Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab.
OBJECTIVE: To evaluate the efficacy/safety of subcutaneous (SC) golimumab in patients with rheumatoid arthritis (RA) who previously received intravenous (IV) golimumab with or without methotrexate (MTX). METHODS: Adult patients with RA (n = 643) with persistent disease despite MTX (≥ 15 mg/wk for ≥...
প্রধান লেখক: | Taylor, P, Ritchlin, C, Mendelsohn, A, Baker, D, Kim, L, Xu, Z, Mack, M, Kremer, J |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
2011
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
THE EFFECT OF GOLIMUMAB ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
অনুযায়ী: L. A. Knyazeva, অন্যান্য
প্রকাশিত: (2018-03-01) -
Golimumab for the treatment of psoriatic arthritis
অনুযায়ী: H Yang, অন্যান্য
প্রকাশিত: (2011-05-01) -
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
অনুযায়ী: Proton Rahman, অন্যান্য
প্রকাশিত: (2020-09-01) -
Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study.
অনুযায়ী: Kremer, J, অন্যান্য
প্রকাশিত: (2010) -
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
অনুযায়ী: M. Rossini, অন্যান্য
প্রকাশিত: (2015-03-01)